OR WAIT null SECS
April 28, 2021
Article
A study characterizing frailty in patients with rheumatoid arthritis finds psychosocial factors could be more important determinants than aging.
April 16, 2021
April 04, 2021
The oral Janus kinase 1 inhibitor abrocitinib produced similar outcomes to dupilumab in a placebo-controlled comparison for atopic dermatitis.
March 31, 2021
Investigators conducted what's believed to be the largest prospective observational studies of response to changing treatment regimens in patients with lupus nephritis who do not respond to initial, first-line therapy.